Physician profile
Hans Michell
NPI 1124415211
$926.24
in general payments reported to CMS, 2019-2025
10 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.15 · 2022: $241 · 2023: $239 · 2024: $263 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $326.18 | 2020-2024 | Embold Fibered |
| Medtronic, INC. | $265.51 | 2022-2025 | Concertotm |
| Penumbra, INC. | $111.13 | 2023-2024 | Ruby Coil, Indigo System |
| Trisalus Life Sciences, INC. | $49.14 | 2025 | Trinav Infusion System |
| Cardiva Medical, INC. | $48.93 | 2022 | |
| Argon Medical Devices, INC. | $34.95 | 2025 | Clot Management |
| Terumo Medical Corporation | $27.95 | 2025 | Azur Cx Detachable |
| Angiodynamics, INC. | $26.58 | 2025 | Alphavac |
| Abbott Laboratories | $20.74 | 2023 | Perclose Prostyle |
| Becton, Dickinson and Company | $15.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Michell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.